Laurence Leclerc

909 total citations
6 papers, 563 citations indexed

About

Laurence Leclerc is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Laurence Leclerc has authored 6 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Laurence Leclerc's work include Thyroid Cancer Diagnosis and Treatment (2 papers), HIV Research and Treatment (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Laurence Leclerc is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (2 papers), HIV Research and Treatment (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Laurence Leclerc collaborates with scholars based in France and United States. Laurence Leclerc's co-authors include E Modigliani, A Boneu, B. Conte‐Devolx, Isabelle Guilhem, Jean‐Claude Bigorgne, R. Cohen, Martin Schlumberger, Isabelle Schuffenecker, Charis Eng and Olivier Chabre and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Critical Care Medicine and Clinica Chimica Acta.

In The Last Decade

Laurence Leclerc

6 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Leclerc France 5 462 211 208 97 88 6 563
Rosa Paula M. Biscolla Brazil 14 448 1.0× 200 0.9× 83 0.4× 55 0.6× 65 0.7× 35 528
Eui Young Kim South Korea 16 832 1.8× 440 2.1× 139 0.7× 92 0.9× 118 1.3× 36 939
Józef Roskosz Poland 10 555 1.2× 298 1.4× 76 0.4× 56 0.6× 101 1.1× 31 613
Bie‐Yu Huang Taiwan 12 519 1.1× 315 1.5× 114 0.5× 99 1.0× 105 1.2× 19 640
H.-D. Röher Germany 10 170 0.4× 112 0.5× 96 0.5× 65 0.7× 117 1.3× 32 419
BM Arafah United States 8 520 1.1× 275 1.3× 96 0.5× 34 0.4× 99 1.1× 12 638
Ahmad Aniss Australia 10 370 0.8× 201 1.0× 55 0.3× 79 0.8× 93 1.1× 22 442
Maryse Brassard France 7 320 0.7× 123 0.6× 63 0.3× 70 0.7× 54 0.6× 10 390
Cristina Pasquini Italy 10 335 0.7× 199 0.9× 52 0.3× 34 0.4× 37 0.4× 15 426
Kimberley Studeman United States 10 233 0.5× 194 0.9× 69 0.3× 173 1.8× 81 0.9× 18 588

Countries citing papers authored by Laurence Leclerc

Since Specialization
Citations

This map shows the geographic impact of Laurence Leclerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Leclerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Leclerc more than expected).

Fields of papers citing papers by Laurence Leclerc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Leclerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Leclerc. The network helps show where Laurence Leclerc may publish in the future.

Co-authorship network of co-authors of Laurence Leclerc

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Leclerc. A scholar is included among the top collaborators of Laurence Leclerc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Leclerc. Laurence Leclerc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Lada, Olivier, Anne Gervais, Michel Branger, et al.. (2011). Quasispecies Analysis and In Vitro Susceptibility of HBV Strains Isolated from HIV–HBV-Coinfected Patients with Delayed Response to Tenofovir. Antiviral Therapy. 17(1). 61–70. 13 indexed citations
2.
d’Herbomez, Michèle, Laurence Leclerc, Marie‐Christine Vantyghem, et al.. (2001). Clinical evaluation of a new sensitive calcitonin assay: study of specificity. Clinica Chimica Acta. 311(2). 149–155. 22 indexed citations
3.
Schuffenecker, Isabelle, Richard M. Brohet, David E. Goldgar, et al.. (1998). Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of theRETProto-Oncogene1. The Journal of Clinical Endocrinology & Metabolism. 83(2). 487–491. 88 indexed citations
4.
Modigliani, E, R. Cohen, B. Conte‐Devolx, et al.. (1998). Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clinical Endocrinology. 48(3). 265–273. 416 indexed citations
5.
Leclerc, Laurence, et al.. (1991). Hypothyroidism following combined treatment for hypopharyngeal and laryngeal carcinoma. The American Journal of Surgery. 162(4). 345–347. 22 indexed citations
6.
Fourrier, François, Laurence Leclerc, P. Lestavel, et al.. (1988). Decrease of angiotensin-converting enzyme activity after plasma exchange. Critical Care Medicine. 16(2). 105–110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026